Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

Organizations that care for people with diabetes have increasingly adopted telemedicine-based diabetic retinopathy screening (TMDRS) as a way to increase adherence to recommended retinal exams. Recently, handheld retinal cameras have emerged as a low-cost, lightweight alternative to traditional bulky tabletop retinal cameras. Few published clinical trials have been performed on handheld retinal cameras. Peer-reviewed articles about commercially available handheld retinal cameras have concluded that they are a usable alternative for TMDRS, however, the clinical results presented in these articles do not meet criteria published by the United Kingdom Diabetic Eye Screening Programme and the American Academy of Ophthalmology. The future will likely remedy the shortcomings of currently available handheld retinal cameras, and will create more opportunities for preventing diabetic blindness.

Download Full-text

Understanding the uptake of a national retinopathy screening programme: An audit of patients with diabetes in two large primary care centres

HRB Open Research ◽

10.12688/hrbopenres.12926.1 ◽

2019 ◽

Vol 2 ◽

pp. 17 ◽

Cited By ~ 1

Author(s):

Marsha Tracey ◽

Emmy Racine ◽

Fiona Riordan ◽

Sheena M. McHugh ◽

Patricia M. Kearney

Keyword(s):

Primary Care ◽

Diabetic Retinopathy ◽

Screening Programme ◽

Primary Care Population ◽

Diabetic Retinopathy Screening ◽

A Priority ◽

Rate Ratios ◽

Measure Of Association ◽

Retinopathy Screening

Background: Diabetic retinopathy (DR) affects 8.2% of the Irish population with type 2 diabetes over 50 years and is one of the leading causes of blindness among working-age adults. Regular diabetic retinopathy screening (DRS) can reduce the risk of sight loss. In 2013, the new national screening programme (RetinaScreen) was introduced in Ireland. Maximising DRS uptake (consent to participate in the programme and attendance once invited) is a priority, therefore it is important to identify characteristics which determine DRS uptake among those with diabetes in Ireland. We report uptake in an Irish primary care population during the initial phase of implementation of RetinaScreen and investigate factors which predict consenting to participate in the programme. Methods: In two primary care practices, data were extracted from records of people with diabetes (type 1 and type 2) aged ≥18 years who were eligible to participate in RetinaScreen between November 2013 and August 2015. Records were checked for a RetinaScreen letter. RetinaScreen were contacted to establish the status of those without a letter on file. Multivariable Poisson regression was used to examine associations between socio-demographic variables and consenting. Adjusted incident rate ratios (IRR) with 95% CI were generated as a measure of association. Results: Of 722 people with diabetes, one fifth (n=141) were not registered with RetinaScreen. Of 582 who were registered, 63% (n=365) had participated in screening. Most people who consented subsequently attended (n=365/382, 96%). People who had attended another retinopathy screening service were less likely to consent (IRR 0.65 [95%CI 0.5-0.8]; p<0.001). Other predictors were not significantly associated with consent. Conclusions: Over one third of people eligible to participate in RetinaScreen had not consented. Research is needed to understand barriers and enablers of DRS uptake in the Irish context. Implementing strategies to improve DRS uptake (consent and attendance) should be a priority.

Download Full-text

Understanding the uptake of a national retinopathy screening programme: An audit of people with diabetes in two large primary care centres

HRB Open Research ◽

10.12688/hrbopenres.12926.3 ◽

2019 ◽

Vol 2 ◽

pp. 17 ◽

Cited By ~ 1

Author(s):

Marsha Tracey ◽

Emmy Racine ◽

Fiona Riordan ◽

Sheena M. McHugh ◽

Patricia M. Kearney

Keyword(s):

Primary Care ◽

Diabetic Retinopathy ◽

Screening Programme ◽

Primary Care Population ◽

Diabetic Retinopathy Screening ◽

A Priority ◽

Rate Ratios ◽

Measure Of Association ◽

Primary Care Practices ◽

Retinopathy Screening

Background: Diabetic retinopathy (DR) is estimated to affect 25–26% of the Irish population with diabetes and is one of the leading causes of blindness among working-age adults. Regular diabetic retinopathy screening (DRS) can reduce the risk of sight loss. In 2013, the new national screening programme (RetinaScreen) was introduced in Ireland. Maximising DRS uptake (consent to participate in the programme and attendance once invited) is a priority, therefore it is important to identify characteristics which determine DRS uptake among those with diabetes in Ireland. We report uptake in an Irish primary care population during the initial phase of implementation of RetinaScreen and investigate factors which predict consenting to participate in the programme. Methods: In two primary care practices, data were extracted from records of people with diabetes (type 1 and type 2) aged ≥18 years who were eligible to participate in RetinaScreen between November 2013 and August 2015. Records were checked for a RetinaScreen letter. RetinaScreen were contacted to establish the status of those without a letter on file. Multivariable Poisson regression was used to examine associations between socio-demographic variables and consenting. Adjusted incident rate ratios (IRR) with 95% CI were generated as a measure of association. Results: Of 722 people with diabetes, one fifth (n=141) were not registered with RetinaScreen. Of 582 who were registered, 63% (n=365) had participated in screening. Most people who consented subsequently attended (n=365/382, 96%). People who had attended another retinopathy screening service were less likely to consent (IRR 0.65 [95%CI 0.5-0.8]; p<0.001). Other predictors were not significantly associated with consent. Conclusions: Over one third of eligible participants in RetinaScreen had not consented. Research is needed to understand barriers and enablers of DRS uptake in the Irish context. Implementing strategies to improve DRS uptake, barriers to consent in particular, should be a priority.

Download Full-text

Towards comprehensive population-based screening for diabetic retinopathy: operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods

Journal of Medical Screening ◽

10.1258/096914106777589669 ◽

2006 ◽

Vol 13 (2) ◽

pp. 87-92 ◽

Cited By ~ 12

Author(s):

JN Harvey ◽

L Craney ◽

S Nagendran ◽

CS Ng

Keyword(s):

Diabetic Retinopathy ◽

Screening Programme ◽

Population Based ◽

Screening Methods ◽

Diabetic Retinopathy Screening ◽

Patient Register ◽

The North ◽

North Wales ◽

Retinopathy Screening

Download Full-text

Use of oral fluorescein angiography in the diagnosis of macular oedema within a diabetic retinopathy screening programme

American Journal of Ophthalmology ◽

10.1016/s0002-9394(02)01442-3 ◽

2002 ◽

Vol 133 (5) ◽

pp. 737-738

Author(s):

Thomas J. Liesegang

Keyword(s):

Diabetic Retinopathy ◽

Fluorescein Angiography ◽

Macular Oedema ◽

Screening Programme ◽

Diabetic Retinopathy Screening ◽

Retinopathy Screening

Download Full-text

Understanding the uptake of a national retinopathy screening programme: An audit of people with diabetes in two large primary care centres

HRB Open Research ◽

10.12688/hrbopenres.12926.2 ◽

2019 ◽

Vol 2 ◽

pp. 17 ◽

Cited By ~ 1

Author(s):

Marsha Tracey ◽

Emmy Racine ◽

Fiona Riordan ◽

Sheena M. McHugh ◽

Patricia M. Kearney

Keyword(s):

Primary Care ◽

Diabetic Retinopathy ◽

Screening Programme ◽

Primary Care Population ◽

Diabetic Retinopathy Screening ◽

A Priority ◽

Rate Ratios ◽

Measure Of Association ◽

Retinopathy Screening

Background: Diabetic retinopathy (DR) affects 8.2% of the Irish population with type 2 diabetes over 50 years and is one of the leading causes of blindness among working-age adults. Regular diabetic retinopathy screening (DRS) can reduce the risk of sight loss. In 2013, the new national screening programme (RetinaScreen) was introduced in Ireland. Maximising DRS uptake (consent to participate in the programme and attendance once invited) is a priority, therefore it is important to identify characteristics which determine DRS uptake among those with diabetes in Ireland. We report uptake in an Irish primary care population during the initial phase of implementation of RetinaScreen and investigate factors which predict consenting to participate in the programme. Methods: In two primary care practices, data were extracted from records of people with diabetes (type 1 and type 2) aged ≥18 years who were eligible to participate in RetinaScreen between November 2013 and August 2015. Records were checked for a RetinaScreen letter. RetinaScreen were contacted to establish the status of those without a letter on file. Multivariable Poisson regression was used to examine associations between socio-demographic variables and consenting. Adjusted incident rate ratios (IRR) with 95% CI were generated as a measure of association. Results: Of 722 people with diabetes, one fifth (n=141) were not registered with RetinaScreen. Of 582 who were registered, 63% (n=365) had participated in screening. Most people who consented subsequently attended (n=365/382, 96%). People who had attended another retinopathy screening service were less likely to consent (IRR 0.65 [95%CI 0.5-0.8]; p<0.001). Other predictors were not significantly associated with consent. Conclusions: Over one third of eligible participants in RetinaScreen had not consented. Research is needed to understand barriers and enablers of DRS uptake in the Irish context. Implementing strategies to improve DRS uptake, barriers to consent in particular, should be a priority.

Download Full-text